Replies to post #753415 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Regarding your #3, I get a different take than you. Per NWBOs PR

The P3 trial SAP states they would use patient level data if available.

Also, even if that is not available, the PIP trials could use the same selection criterion as the selected ECA,